USPTO serial 79101583
ARIVINE
Reviewed by CopyMark Law Group
Reg. 4243987Status 404
- Filing date
- Status date
- Registration date
- Nov 20, 2012
- Examiner
- WIENER, MICHAEL
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ARIVINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aimee L. Kaplan
AIMEE L. KAPLAN COLLARD & ROE, P.C.1077 NORTHERN BLVD.ROSLYN, NY 11576UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Cosmetic agents, namely, lotions, creams, emulsions, and microemulsions for body, hair and skin beauty caring; cosmetic agents, namely, fluids, gels, and sprays for the body and the skin; body, hair and skin cleansing cosmetic agents, namely, cleansing lotions, fluids, gels, sprays, emulsions, microemulsions in the nature of body, hand, eye, skin, facial lotions, body, hand, skin, and facial creams, shower gels, body and skin beauty creams, soaps; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions, all for regenerating connective tissue; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for leg caring; non-medicated cosmetic vein caring agents, namely, lotions, fluids, gels, sprays, creams, emulsions, and micro-emulsions; non-medicated cosmetic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, micro-emulsions, all for covering hematoma ] | SECTION 7(e) - CANCELLED | — |
| 005 | [ Medical anti-itching agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; anti-allergic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical wound healing agents, namely, medicated lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical agents for treating hematoma, namely, medicated lotions, fluids, gels, sprays, creams, emulsions, microemulsions; hygienic preparations for medical purposes, namely, hygienic lotions, fluids, gels, sprays, emulsions, microemulsions, pads, tissues, bandages, antibacterial hand lotions; antimycotic agents, namely, medicated capsules, tablets, and dragees; medicated antimycotic lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for medical purposes; antibacterial agents, namely, capsules, tablets, dragees, antibacterial lotions, fluids, gels, sprays, creams, emulsions, microemulsions, all for medical purposes as far as comprised by International Class 5; antiviral agents, namely, capsules, tablets, dragees, antiviral lotions, fluids, gels, sprays, creams, emulsions, microemulsions for medical purposes; medical anticoagulation agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions; medical anesthetic agents for surgical use, namely, capsules, tablets, dragees, injection fluids, lotions, gels, sprays, creams, emulsions, microemulsions; medical skin and body treating agents in the nature of lotions, fluids, gels, sprays, creams, sprays, fluids, emulsions, microemulsions for skin care and beauty; medical analgesic agents, namely, lotions, fluids, gels, sprays, creams, emulsions, microemulsions, injection fluids; pharmaceutical and veterinary preparations in the form of fluids, emulsions, microemulsion, creams for treating pain, inflammation, infection, trauma; medical preparations in the form of microemulsions for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; veterinary preparations in the form of microemulsions for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma for mammals such as horses, dogs, pigs, cats; intra and transcutaneous pharmaceutical-medical injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts for treating pain, inflammation, infection, trauma, wounds, injuries, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; anti-inflammatory injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts, analgesic anesthetic surgical or non surgical injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts; injection agents, namely, water, solvents, suspensions, emulsions, inorganic and organic salts for treating neuralgia, eczema, neurodermatitis, and diabetic disease; injection syringes for medical purposes; topically sub, intra and transdermally applicable pharmaceutical medical skin and mucosa preparations, namely, lotions, fluids, gels, sprays, creams, emulsions, and microemulsions, all for medical skin and body care treatment; medical-pharmaceutical preparations, namely, topical agents such as, gels, emulsions, microemulsions for treating sports injuries, pain, rheumatism, neuropathy, neuralgia, gout, mycosis, infections, scabies, neurodermatitis, eczema, and hematoma; ] surgical implants comprising living tissue | SECTION 71 - CANCELLED | — |
| 010 | Surgical instruments and apparatus; medical and dental instruments and apparatus, namely, medical fluid injectors, and insulin injectors sold empty, drainage tubes, cannulae, surgical clips, scissors, needles, dispensers for applying medicines, medical, dental and/or veterinary testing apparatus, namely, blood testing apparatus for medical purposes, all for use in surgery, and in treating injuries, trauma, infections, fractures, and lesions; veterinary instruments and apparatus, namely, medical fluid injectors, and insulin injectors sold empty, drainage tubes, cannulae, surgical clips, scissors, needles, dispensers for applying medicines, medical, dental and/or veterinary testing apparatus, namely, blood testing apparatus for medical purposes, all for use in surgery, and in treating injuries, trauma, infections, fractures, and lesions; medical atomizing apparatus for atomizing fluids, emulsions, and micro-emulsions; vaporizer for medical purposes, namely, electric vaporizers for upper respiratory conditions | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MedDrop Technology AG
- Other trademarks owned by MedDrop Technology AG
- Other trademarks owned by MedDrop Technology AG
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ARIVINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 28, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 28, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 5, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 14, 2020 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 14, 2020 | INPC | INVALIDATION PROCESSED | — |
| Feb 21, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 28, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 21, 2019 | C71T | CANCELLED SECTION 71 | — |
| Jun 23, 2014 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Dec 19, 2013 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 19, 2013 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 19, 2013 | PLGL | ASSIGNED TO PARALEGAL | — |
| Apr 19, 2013 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Apr 6, 2013 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Mar 25, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 25, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 25, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 20, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 20, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 15, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 4, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 15, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 15, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 27, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 18, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 26, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 11, 2012 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 23, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2012 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 5, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 16, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 9, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 16, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 15, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 8, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |